Cardio Diagnostics Holdings, Inc. (CDIO): Debts to Book Capitalization

Brandmark of cardiodiagnosticsinc.com (CDIO)

How can Cardio Diagnostics (CDIO) make cardiac screening mass-market through AI and epigenetics? The total debt-to-market capitalization ratio demonstrates a downward trend, where 0.05 serves as the base parameter value. Stable demand for diagnostics and insurance coverage ensure macro-stability, while the leadership's scientific potential helps optimize expenses amid limited capital for scaling the platform.

CDIO Cardio Diagnostics Holdings Debt to Book Value Ratio (04/28/2023 - 10/27/2026)
Original product of Cardio Diagnostics Holdings Inc.

This ratio compares total liabilities to equity to assess the degree of financial leverage. It determines the business's dependence on external financing and the risk of insolvency during market volatility. Monitoring borrowed funds relative to balance sheet capital allows an investor to evaluate the stability of the asset structure. For Cardio Diagnostics (CDIO), this balance is critical when scaling AI solutions. Debt optimization will ensure the secure implementation of personalized genetic tests.

Competitors of Cardio Diagnostics

A - Debts to Book Capitalization|Debt to Book Value Ratio questdiagnostics.com DGX|Illumina - Debts to Book Capitalization|EXAS: Debts to Book Capitalization|Debt to Book Capitalization Ratio PerkinElmer|Bio-Rad Corp (BIO) - Debt to Book Value Ratio|NNNN (Anbio Biotechnology) - Debts to Book Capitalization|Debts to Book Capitalization SHC|Debt to Book Capitalization Ratio QuidelOrtho Corporation (QDEL)|Debt to Book Capitalization Ratio OPKO Health Inc OPK|CDNA: Debt to Book Value|Maravai - Debts to Book Value|Debt to Book Capitalization Ratio FLGT (Fulgent Genetics, Inc.)|LAB - Debts to Net Assets|Cytek Biosciences - Debts to Book Capitalization|OSUR (OraSure Technologies, Inc.) - Debts to Net Assets|XGN: Debt to Book Capitalization Ratio|Debts to Net Assets MDxHealth, Inc.|Debts to Book Capitalization LUCD (Lucid Diagnostics Inc.)|Debt to Book Value prenetics.com (PRE)|Debts to Book Capitalization IMDX (Insight Molecular Diagnostics Inc)|Trinity Biotech PLC - Debts to Book Capitalization|Debt to Book Capitalization Ratio ProPhase (PRPH)|AIMD - Debt to Net Assets Ratio|Debts to Book Capitalization Co-Diagnostics, Inc.|heartsciences.com (HSCS) - Debt to Book Value Ratio|BMRA: Debts to Book Capitalization|Debts to Net Assets VRAX|Bluejay - Debt to Book Capitalization Ratio|Debts to Book Value Aspira Women's Health Inc AWH|Debt to Book Value Accelerate Diagnostics|Debt to Net Assets Ratio centogene.com CNTG|Enzo (ENZ) - Debts to Book Capitalization|FRES - Debt to Book Value Ratio|gtglabs.com - Debts to Book Capitalization|23andMe Inc (ME) - Debts to Net Assets|PMD (Psychemedics) - Debts to Book Capitalization